Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qinglong Tuomin Decoction
- Development stage
- Preclinical
- Lead developer
- Dongguan Maternal and Child Health Care Hospital
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Qinglong Tuomin Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of allergic rhinitis, particularly in pediatric populations. The name suggests it is a modification of the classic 'Xiao Qinglong Tang' (Minor Blue Dragon Decoction), specifically optimized for 'Tuomin' (desensitization or anti-allergy) effects. It is typically administered as an oral decoction. The formula is intended to alleviate symptoms such as sneezing, rhinorrhea, and nasal congestion by modulating the immune response and reducing allergic inflammation. It has been studied in clinical trials, such as ChiCTR2300072470, both as a standalone treatment and in combination with conventional antihistamines like levocetirizine to improve clinical outcomes and reduce recurrence rates in children.
- Brand names
- Qinglong Tuomin Tang
- Other names
- Qinglong Tuomin Tang青龙脱敏汤
02
Targets
IgE (Immunoglobulin E)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on Qinglong Tuomin Decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qinglong Tuomin Decoction.